Purespring Therapeutics - LinkedIn
Purespring Therapeutics on LinkedIn: #research #kidneydisease #event # ...biomodal on LinkedIn: #liquidbiopsy #epigenetics #epigenomicsDavina Patel, PhD - Scientist - Purespring Therapeutics - LinkedIn
OFF
Purespring Therapeutics Raises £80/$105 Million In A Series
2 days from now
London – 9 October 2024 - Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised …
biospace.com
OFF
Ian Pitfield - CGT CMC Consultant - LinkedIn
2 days from now
𝐅𝐫𝐨𝐦 𝐋𝐨𝐧𝐝𝐨𝐧: Purespring Therapeutics raised a $105M series B earlier this month to advance AAV gene therapies for kidney diseases… Liked by Ian Pitfield. I am delighted to showcase Five Alarm …
linkedin.com
OFF
Iskander Shadid - Analyst - Gilde Healthcare - LinkedIn
2 days from now
Purespring Therapeutics has raised £80 million ($105 million) in an… Forbion Proudly Backs Purespring Therapeutics in Series B Financing. Purespring Therapeutics has raised £80 …
linkedin.com
OFF
Sander Slootweg - Forbion - LinkedIn
2 days from now
Purespring Therapeutics has raised £80 million ($105 million) in an… Forbion Proudly Backs Purespring Therapeutics in Series B Financing. Purespring Therapeutics has raised £80 …
linkedin.com
OFF
TG Therapeutics Price Target Raised To $43 From $30 At JPMorgan
2 days from now
2 days ago · JPMorgan raised the firm’s price target on TG Therapeutics to $43 from $30 and keeps an Overweight rating on the shares. The firm says that with a potential SC Briumvi …
businessinsider.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
